County
Thurston County Medic One
Thurston County Medic One (Olympia, WA) carries 42 drugs across 148 dose entries in its current published protocol, effective 2026-04-01.
Drugs and doses42
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Pediatric fever | peds | 15 mg/kg | PO | not captured | standing | page 98 |
| Seizure | peds | 15 mg/kg | PO | not captured | standing | page 47 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 g | PO | not captured | standing | page 99 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 99 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 74 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 74 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 5 mg | NEB | not captured | standing | page 19 |
| Allergic reaction | peds | 2.5 mg | NEB | not captured | standing | page 19 |
| Asthma / bronchospasm | adult | 10 puff | MDI | not captured | standing | page 101 |
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | page 25 |
| Asthma / bronchospasm | adult | 5 puff | MDI | not captured | standing | page 101 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 25 |
| Hyperkalemia | adult | 15 mg | NEB | not captured | standing | page 101 |
Albuterol-Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 102 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 102 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | page 74 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 69 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 69 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 27 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 73 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 73 |
| Organophosphate poisoning | adult | 1 mg | IV | not captured | standing | page 105 |
| Organophosphate poisoning | adult | 1 mg | IV | not captured | standing | page 105 |
| RSI induction | peds | 0.01 mg/kg | IV | not captured | standing | page 105 |
Buprenorphine-Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 16 mg | SL | not captured | standing | page 106 |
| Other | adult | 16 mg | SL | not captured | standing | page 106 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | peds | 10–20 mg/kg | IV | not captured | standing | page 107 |
| Burns | adult | 1 g | IV | not captured | standing | page 107 |
| Burns | peds | 10–20 mg/kg | IV | not captured | standing | page 107 |
| Hyperkalemia | adult | 1 g | IV | not captured | standing | page 107 |
| Hyperkalemia | peds | 10–20 mg/kg | IV | not captured | standing | page 107 |
| Other | adult | 1 g | IV | not captured | standing | page 107 |
| Other | adult | 500 mg | IV | not captured | standing | page 43 |
| Other | peds | 10–20 mg/kg | IV | not captured | standing | page 107 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 107 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV | not captured | standing | page 109 |
| Hypoglycemia | adult | 25 g | IV | not captured | standing | page 110 |
| Hypoglycemia | peds | 1 g/kg | IV | not captured | standing | page 109 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10 mg | IV | not captured | standing | page 111 |
| Atrial fibrillation with RVR | adult | 10 mg | IV | not captured | standing | page 111 |
| Other | adult | 10 mg | IV | not captured | standing | page 111 |
| SVT | adult | 10 mg | IV | not captured | standing | page 111 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IM | not captured | standing | page 19 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 19 |
| Dystonic reaction | adult | 25–50 mg | IV/IM | not captured | standing | page 112 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 112 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 73 |
| Hypotension / shock | adult | 2–50 mcg/kg | IV/IO | not captured | standing | page 113 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV | not captured | standing | page 22 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 22 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 19 |
| Anaphylaxis | adult | 0.3 mg | IV | not captured | standing | page 19 |
| Anaphylaxis | peds | 0.01 mg/kg | IV | not captured | standing | page 19 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 19 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 25 |
| Asthma / bronchospasm | adult | 5 mL | not captured | not captured | standing | page 25 |
| Asthma / bronchospasm | peds | 0.5 mL/kg | not captured | not captured | standing | page 25 |
| Bradycardia | adult | 5–20 mcg | IV/IO | not captured | standing | page 115 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 69 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 69 |
| Croup | peds | 0.5 mL/kg | not captured | not captured | standing | page 25 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.15 mg/kg | IV | not captured | standing | page 117 |
| RSI induction | adult | 0.3 mg/kg | IV | not captured | standing | page 117 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 50–100 mcg | IV | not captured | standing | page 118 |
| Severe pain | peds | 1 mcg/kg | IV | not captured | standing | page 118 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | page 25 |
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | page 25 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg | IV | not captured | standing | page 19 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IM/IN/SQ | not captured | standing | page 121 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IM/IN/SQ | not captured | standing | page 121 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 121 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV | not captured | standing | page 22 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 22 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 108 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.3 mg/kg | IV | not captured | standing | page 12 |
| Severe pain | peds | 0.1–0.3 mg/kg | IV | not captured | standing | page 12 |
| Procedural sedation | adult | 1–2 mg/kg | IV | not captured | standing | page 22 |
| Procedural sedation | adult | 2–4 mg/kg | IM | not captured | standing | page 22 |
| Procedural sedation | peds | 1–2 mg/kg | IV | not captured | standing | page 22 |
| Procedural sedation | peds | 2–4 mg/kg | IM | not captured | standing | page 22 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 10 mg | IV | not captured | standing | page 12 |
| Mild to moderate pain | adult | 15–30 mg | IM | not captured | standing | page 12 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Status epilepticus | adult | 20 mg/kg | IV | not captured | standing | page 47 |
| Status epilepticus | peds | 20 mg/kg | IV | not captured | standing | page 47 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–1.5 mg/kg | IV | not captured | standing | page 126 |
| Other | adult | 40 mg | IO | not captured | standing | page 126 |
| Other | adult | 50 mg | NEB | not captured | standing | page 126 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV | not captured | standing | page 69 |
| VF / pulseless VT | peds | 1 mg/kg | IV | not captured | standing | page 69 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 25 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | page 43 |
| Other | adult | 2 g | IV | not captured | standing | page 127 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | page 127 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV | not captured | standing | page 128 |
| Adrenal crisis | peds | 1 mg/kg | IV | not captured | standing | page 128 |
| Allergic reaction | adult | 125 mg | IV | not captured | standing | page 128 |
| Allergic reaction | peds | 1 mg/kg | IV | not captured | standing | page 128 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | page 25 |
| Asthma / bronchospasm | peds | 1 mg/kg | IV | not captured | standing | page 25 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 5 mg | IV | not captured | standing | page 129 |
| Atrial fibrillation with RVR | adult | 5 mg | IV | not captured | standing | page 129 |
| Other | adult | 5 mg | IV | not captured | standing | page 129 |
| SVT | adult | 5 mg | IV | not captured | standing | page 129 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IV | not captured | standing | page 130 |
| Procedural sedation | adult | 2–10 mg | IV/IO/IM/IN | not captured | standing | page 130 |
| Procedural sedation | peds | 0.2 mg/kg | IV/IO/IM/IN | not captured | standing | page 130 |
| Status epilepticus | adult | 5 mg | IM | not captured | standing | page 130 |
| Status epilepticus | adult | 5 mg | IN | not captured | standing | page 130 |
| Status epilepticus | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 130 |
| Status epilepticus | peds | 0.2 mg/kg | IM | not captured | standing | page 130 |
| Status epilepticus | peds | 0.2 mg/kg | IN | not captured | standing | page 130 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN/SL/ET | not captured | standing | page 131 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN/SL/ET | not captured | standing | page 131 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 133 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 133 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 133 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 133 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–50 mcg | IV | not captured | standing | page 135 |
| Hypotension / shock | adult | 2–50 mcg | IV | not captured | standing | page 135 |
| Hypotension / shock | peds | 0.05–2 mcg/kg | IV | not captured | standing | page 135 |
| Hypotension / shock | peds | 0.05–2 mcg/kg | IV | not captured | standing | page 135 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/SL | not captured | standing | page 137 |
| Nausea / vomiting | adult | 4 mg | IV/SL | not captured | standing | page 137 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/SL | not captured | standing | page 137 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/SL | not captured | standing | page 137 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IV | not captured | standing | page 32 |
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 32 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5–25 mg | IM | not captured | standing | page 140 |
| Nausea / vomiting | adult | 6.25–12.5 mg | IV | not captured | standing | page 140 |
| Nausea / vomiting | peds | 0.25 mg/kg | IV | not captured | standing | page 140 |
| Nausea / vomiting | peds | 0.5 mg/kg | IM | not captured | standing | page 140 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2 drop | not captured | not captured | standing | page 141 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.6–1.2 mg/kg | IV | not captured | standing | page 142 |
| RSI induction | peds | 0.6–1.2 mg/kg | IV | not captured | standing | page 142 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV | not captured | standing | page 143 |
| Cardiac arrest | peds | 1 mEq/kg | IV | not captured | standing | page 143 |
| Hyperactive delirium | adult | 1 mEq/kg | IV | not captured | standing | page 143 |
| Hyperactive delirium | peds | 1 mEq/kg | IV | not captured | standing | page 143 |
| Hyperkalemia | adult | 1 mEq/kg | IV | not captured | standing | page 143 |
| Hyperkalemia | peds | 1 mEq/kg | IV | not captured | standing | page 143 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | page 143 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | page 143 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5–2 mg/kg | IV | not captured | standing | page 144 |
| RSI induction | peds | 1.5–2 mg/kg | IV | not captured | standing | page 144 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 100 mg | IV/IM | not captured | standing | page 145 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 2 g | IV | not captured | standing | page 32 |
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 23 |
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 146 |